Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 12/8/2009
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 0||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Surgery, Mitochondrial cytopathy
Life Threatening? Yes
Permanent Disability? Yes
ER or Doctor Visit? Yes
Other Medications: Unknown
Current Illness: Cardiac septal defect
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES0906USA01886
Write-up:Information has been received from a physician concerning a female patient who was vaccinated with GARDASIL. The patient received the first dose of GARDASIL and a week and half later she was scheduled to have heart surgery due to a hole in a heart that patient already had. Then after surgery the patient started to experience illness on a mitochondrial level. The physician stated that the patient was hospitalized due to surgery but did not specify how long the patient was in the hospital. Illness on a mitochondrial level was considered to be immediately life-threatening and disabling. At the time of this report, the patient was recovering. No further information is available.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166